A Bayesian approach to analysing data from family-based association studies is developed. This permits direct assessment of the range of possible values of model parameters, such as the recombination frequency and allelic associations, in the light of the data. In addition, sophisticated comparisons of different models may be handled easily, even when such models are not nested. The methodology is developed in such a way as to allow separate inferences to be made about linkage and association by including θ, the recombination fraction between the marker and disease susceptibility locus under study, explicitly in the model. The method is illustrated by application to a previously published data set. The data analysis raises some interesting issues, notably with regard to the weight of evidence necessary to convince us of linkage between a candidate locus and disease.
INTRODUCTION
There has been considerable recent interest in developing methods to map disease susceptibility loci using family-based association studies, with a number of methods suitable for multi-allelic markers now available (see e.g. Spielman and Ewens, 1996; Curnow et al., 1998) . However, all these methods are based within the frequentist statistical framework, in general providing a test of the compound null hypothesis that the marker under consideration is unlinked to a disease locus or there is no association between alleles at the marker and disease loci. In this paper we show how association mapping can be done within the Bayesian statistical framework. We illustrate how information regarding individual model parameters is naturally represented in the form of posterior probability distributions whilst the relative merits of different models can be assessed through the use of Bayes factors. We shall see that this then allows the possibility of making separate inferences about the linkage and the association between marker and disease locus.
Our approach uses the likelihood derived for random mating populations by Sham and Curtis (1995) , although our notation differs slightly from theirs. Based only on the assumption of a homogeneous randomly mating population, they show that for a marker locus with alleles M i and a disease locus with disease allele D 1 and normal allele D 2 the probability, ρ i j , that a parent of an affected child has marker alleles M i and M j and transmits allele M i to the child is given by
where p is the relative frequency of the disease allele, m i is the relative frequency of marker allele i, θ is the recombination fraction between the disease and marker loci and 1 − B is the ratio of the probability that a chromosome of an affected child has a normal allele at the disease locus to the same probability for a random chromosome in the population. Sham and Curtis comment that in principle (1.1) could be used to estimate θ via maximum likelihood, but do not implement this approach. Instead they suggest that since interest is typically in associations with alleles at marker loci in close proximity to the disease locus it is reasonable to assume that no recombinations occur in the parental chromosomes transmitted to the child so that θ = 0. Under such circumstances equation (1.1) reduces to ρ i j = m i m j b i where
The b i can be interpreted as allelic association parameters since in the case of no association b i = 1, whilst positive and negative values of b i correspond to positive and negative association of marker allele i with the disease. Sham and Curtis derive a likelihood ratio test based on this, which they call the ETDT. Wicks and Wilson (1999) give a more explicit interpretation of b i as the ratio of the conditional probability that a randomly selected child is affected given the parent transmits marker allele i to the marginal probability that such a child is affected. Although not stated there we note that an equivalent interpretation is that b i is the ratio of the conditional probability that the parent transmitted marker allele i given the child is affected to the marginal probability that the parent transmitted marker i. Wicks and Wilson effectively rewrite (1.1) as
and maximize this over θ to produce a likelihood ratio test of the hypothesis that θ = 1/2. However, they do not explore the consequences of this generalization of the Sham and Curtis model in detail. We shall do so here, using a Bayesian approach. Whilst the use of Bayesian methods in genetic epidemiology is relatively uncommon, interest in their use seems to be growing. For example, Vieland (1998) advocates their use in linkage studies on the grounds that they permit a direct measurement of the posterior probability of linkage. More recently, George and Laud (2002) discuss a Bayesian approach to detecting linkage in the special case of a diallelic marker. The Bayesian approach has two key advantages here. Firstly, it directly answers the question of interest by providing a probability distribution for disease gene location; secondly, it allows prior information, for example from previous studies, to be easily incorporated into the analysis. These advantages are particularly compelling when the results of a study, say of a candidate locus, are not conclusive taken alone, but it is still necessary to make a decision about whether to allocate further resources to studying the locus. In our opinion, the Bayesian approach has the further advantage of facilitating choice between models of linkage and no linkage.
STATISTICAL METHODS
Here we work with a reparametrization of (1.3). Letting a i denote the conditional probability of transmission of marker allele M i given the child is affected, we have
so that
We shall see that adopting this alternative parameterisation leads to some advantages in a Bayesian analysis. For a random sample of n parents of n affected children we obtain the log-likelihood
where n i j is the number of parents transmitting marker allele i and not transmitting marker allele j. In practice families rather than parents of affected children are sampled with both parents of each child being included in the evaluation of (1.1). This is only strictly valid in the case of a multiplicative disease, since for other disease models the parental transmissions are dependent after conditioning on the child being affected by the disease (Curnow et al., 1998) . However, dependency between parental transmissions is likely to be low for most complex disease models, particularly since we only require independence of marker transmissions and any non-independence of transmission at the disease locus is attenuated by incomplete association between the marker and disease loci. Further evidence for this is given in the discussion.
Parameter estimation
We first specify prior distributions on the unknown model parameters. In the absence of substantial prior knowledge we propose assuming that a priori m, a and θ are independently distributed with
Note that this includes a uniform prior, often said to represent prior ignorance on the parameters, by setting α i = β i = 1 for all i and γ 1 = γ 2 = 1. We stress that we do not need to assume a uniform prior distribution. For instance, setting γ 1 = γ 2 = 1/2 gives a prior distribution for θ which favours values close to 0 or 1/2. However, if the intention is to test for linkage or tight linkage we prefer to adopt a model comparison approach as discussed in Section 2.2. For a model in which we assume tight linkage, i.e. θ = 0, reparametrization according to equation (2.2) together with the above prior distributions for m and a leads to an analytical form for the posterior distribution in which m and a are a posteriori independently distributed as Dirichlet random variables, i.e.
(2.8)
Hence it is possible to show that, ignoring other parameters, a i and m i follow independent Beta(α i + n i. , j =i (α j + n j. )) and Beta(
that the posterior distribution of b i follows that of a ratio of two independent Beta distributions. Although such a distribution does not have an analytic density function, it is relatively simple to obtain moments of the distribution analytically and to estimate the density by numerical methods or simulation. We shall see that even if the distributions of a i and m i are well-behaved, the posterior distribution of b i need not be. We therefore propose an alternative allelic association parameter
Values of δ i = 0 correspond to no association, whilst δ i < 0 and δ i > 0 correspond to negative and positive association respectively. Except in the special case θ = 0 analytic forms for the posterior distributions of θ , a and m do not exist. Instead we obtain samples from the posterior distribution using Markov chain Monte Carlo (MCMC) via the Metropolis-Hastings algorithm (Metropolis et al., 1953; Hastings, 1970) . Useful introductions to the MCMC approach to inference are given in Gilks et al. (1996) and Tanner (1996) . (Further details of our approach together with the associated code are available as supplementary material from the Biostatistics website at http://www.biostatistics.oupjournals.org.)
Given a set of samples from the posterior distribution of θ, a and m we can estimate arbitrary features of the distribution such as marginal density functions, moments and credible intervals for the individual parameters. These features can be used to summarize the joint posterior distribution of the model parameters given the data.
Model comparison
We have already seen how θ = 0 and θ = 1/2 are important special cases of the more general model. The weight of evidence for the different models compared to the general model is readily assessed in a Bayesian analysis through Bayes Factors (Good, 1958) . The article by Kass and Raftery (1995) provides a thorough overview of this area. Briefly, suppose we are comparing two models M 0 and M 1 with associated (vectors of) parameters ψ 0 and ψ 1 and that a priori the relative probability of M 1 compared to M 0 is given by π 10 . Then, having observed the data, the relative posterior probability of model M 1 to M 0 is given by π 10 × B 10 where B 10 is the Bayes factor for M 1 compared to M 0 given by
where f (data|ψ i ) is the probability of the data under model M i given ψ i and f (ψ i ) is the prior density for ψ i under model M i . The term B 10 is the same regardless of what the relative prior probability of the two models is believed to be. The Bayes factor therefore indicates how the relative plausibility of the two models should be altered in light of the evidence provided by the data. It can be interpreted as the relative posterior probability of the two models that would be obtained if they had been equally plausible before the data had been observed. It has been suggested that Bayes factors could be used in a similar manner to a likelihood ratio. Following Jeffreys (1961) (Copeman et al., 1995) Transmitted It should be noted, however, that if a priori model M 0 is much more likely than model M 1 , a large value of the Bayes factor might still not be enough to suggest that a posteriori M 1 is the more likely of the two models. Furthermore, although the Bayes factor does not depend on the prior probabilities of the two models, it does depend on the prior densities assigned to the parameters of the two models.
As can be seen from (2.10), calculation of the Bayes factor involves integration over the parameter space which is often a non-trivial exercise. Various methods have been proposed for obtaining numerical approximations to it. The article by Kass and Raftery (1995) is a useful starting point on this subject. In applying the methodology to real data in the next section we initially tried to use Laplace approximation methods (Tierney and Kadane, 1986) . This proved to be problematic in general due to some models leading to posterior modal values on or very near to the boundary of the parameter space. Instead we have again resorted to MCMC based methods using what amounts to a special case of the reversible-jump approach proposed by Green (1995) by introducing an additional parameter k to index the two models under consideration and setting an arbitrary value for their relative a priori probability in order to achieve approximately equal visitation of both models. Further details of how this was carried out are given in the supplementary material referred to earlier.
RESULTS
We illustrate our Bayesian approach with data on 180 Sardinian families used to investigate association between insulin-dependent diabetes mellitus (IDDM) and marker locus D2S152 (Curnow et al., 1998) . The data consist of 180 nuclear families each containing at least one child affected by IDDM and are an enhancement of data on 111 families previously reported by Copeman et al. (1995) . To avoid the problems associated with multiple affected children within a single family noted by Spielman and Ewens (1996) a single child has been randomly selected from families with more than one affected child. The data are given in Table 1 .
We first consider analysis of the case where the marker and disease loci are believed to be tightly linked, i.e. θ = 0. For illustrative purposes we further assume that nothing is known about the allele frequencies m or the transmission probabilities a so they are taken to be independently uniform on the 11-dimensional simplex. As discussed earlier this prior gives rise to a posterior distribution which can Table 2 gives exact means, standard deviations and 95% credible intervals for the two sets of association parameters. The 95% credible intervals for the allelic associations confirm the results of previous analyses of the data (Morris et al., 1997) suggesting that alleles 3 and 4 are positively and negatively associated with the disease allele respectively whilst the other alleles do not show association with the disease allele. The findings on alleles 3 and 4 are consistent with the original findings of Copeman et al. (1995) on the initial data. They originally found evidence of association for a third allele, but this is not found in the enlarged dataset. We note that the distributions of δ i appear much better behaved than those of b i . In particular the distribution of b 12 does not have finite variance. The problem arises because b i is a ratio of two random variables and in some cases the denominator random variable m i , the allele frequency, has both a small mean and a relatively large variance. This induces an instability in the distribution of b i , and leads us to favour our alternative parameterisation in terms of δ i .
Having analysed a model in which the recombination frequency was fixed at zero, we now treat θ as unknown and obtain its posterior distribution given the data. We do this using a MetropolisHastings algorithm, details of which may be found in the supplementary material. Table 3 gives numerical summaries of the marginal posterior distributions of δ i , b i and θ.
The posterior distribution for θ is somewhat surprising. Given the data, it appears that the expected value of the recombination fraction is around 0.3. Although there is a great deal of uncertainty surrounding θ, we are still 95% sure that it is between 0.16 and 0.42. If the recombination fraction were as high as this we would expect any allelic association due to linkage disequilibrium to have been eroded by recombinations in the generations since the founding mutation. We discuss this phenomenon further below.
Examination of the posterior information on the allelic associations δ i still suggests that alleles 3 and 4 are associated with the disease allele. However, there is now much more uncertainty in the strength of this association, as indicated by the approximate doubling of the posterior standard deviation when compared to the model with θ = 0. We also note further indications of the poor distributional properties associated with using b i for assessing allelic association in the cases of alleles 1, 7, 11 and 12 which have very high standard deviations. Finally, we consider a model in which the marker and disease loci are assumed to be unlinked. We have again obtained the posterior distribution of the model parameters using the Metropolis-Hastings algorithm as before except that θ is kept fixed at 1/2. In this case the posterior distribution is multi-modal. This is because when θ = 1/2 the log-likelihood is L(a, m) = n i j log (a i m j + a j m i )/2 = L(m, a). Since we have assumed uniform priors in our analysis, this leads to potential multi-modality in the posterior distribution. A further consequence is that the marginal posterior distributions of a i and m i are identical. However, it is not true to say that a i and m i are equal, as is clearly illustrated by the numerical summaries for the association parameters in Table 4 . Yet again, the standard deviations for the b i reveal the poor behaviour of this parameter as a measure of association. As the distributions of the δ i are symmetric about zero all δ i have mean zero. For these data all the 95% credible intervals include zero. In principle this need not be the case. We could have a 95% credible interval made up of two disjoint intervals which excluded zero if the multi-modality were extreme enough. This suggests that such a Bayesian analysis could in some circumstances show that loci were associated but unlinked. Since δ i = a i − m i we have
, hence we are likely to have most chance of detecting association for unlinked loci in the case of a recessive disease (for which B = 1) with a rare marker allele which is strongly associated with the disease allele.
Comparison of models
In addition to the three models considered above we have also considered the possibility that there is no linkage or association between the marker and disease loci, in which case ρ i j = m i m j , and the possibility that the ρ i j are not structured in any way (other than summing to one). This latter model corresponds to a saturated multinomial model for the cell counts of the transmission/non-transmission contingency table. Various Bayes factors for comparing different pairs of models assuming uniform prior distributions throughout are given in Table 5 . Note that from (2.10), B 12 = B 10 /B 20 , so we can obtain other Bayes factors by appropriate division. The Bayes factors indicate that if we were to regard all the models described above equally likely a priori the best explanation for the Sardinia data is a model with no association. However, if we restrict our attention to the models involving θ , we conclude there is strong evidence against tight linkage (θ = 0) in favour of θ ∈ (0, 1/2). As a comparison, Tables 6 and 7 give results of a number of likelihood ratio tests and the values of AIC and BIC. For the likelihood ratio tests with a null hypothesis of θ = 0 or θ = 1/2 the usual asymptotic χ 2 approximation is no longer valid because θ is a boundary value. Self and Liang (1987) give improved approximations and it is these p-values that are quoted here. Both likelihood ratio testing and AIC would indicate that an association model with θ ∈ (0, 1/2) is significantly better than the others under consideration. On the other hand, Schwarz's BIC, which adopts a more severe penalty for each parameter in the model and can be regarded as an approximation of the Bayes factor, favours the no-association model. 
DISCUSSION
The method developed here allows us, in principle, to make separate inferences about linkage and association using family data. However, application to the data of Curnow et al. (1998) raises some interesting issues. Copeman et al. (1995) state that the Sardinian population is genetically isolated and homogeneous. This lends support to the use of the likelihood given in (1.1). However, as noted above, it is implausible that association could be maintained by linkage if θ was around 0.3 as our analysis of these data would suggest. One possibility might be that the use of a likelihood which implicitly assumes a multiplicative disease model leads to a misleading posterior distribution for θ . As discussed earlier, we do not believe this to be the case since we expect the likelihood to be robust to deviations from this ideal. To illustrate this we have simulated data from a highly non-multiplicative disease model in which P(Diseased|D 1 D 1 ) = 0.075, P(Diseased|D 1 D 2 ) = 0.003 75 and P(Diseased|D 2 D 2 ) = 0.000 75, with other parameters such as marker allele relative frequencies and recombination parameter chosen to be consistent with the estimates obtained from the Sardinia data of Section 3. To aid comparison we have simulated data to give us 312 families with an affected child. (312 is the total number of parents in the original Sardinian data.) We have split these data into two independent datasets of 156 families using both parents and two datasets using all 312 families but either the mother or the father only. Our likelihood is therefore valid for the later two datasets. Figure 1 gives the resulting marginal posterior distributions for θ . It is clear that in spite of the disease model being highly non-multiplicative the posterior distributions obtained by treating parental transmissions as independent are reasonably consistent with those based on a single parent; certainly any effect of the non-independence is small compared with the sampling variability.
There therefore seem to be three alternative explanations for the large value of θ . Firstly, we could have loose linkage together with association due to, for example, population stratification. The results of Whittaker et al. (2000) suggest this is possible, but it would be surprising to find hitherto unobserved population structure of the required magnitude. Secondly, we could have tight linkage with θ pushed away from its true value near zero because of failure of model assumptions. This is certainly possible: analysis of simulated data suggests that non-random mating in the parents can cause such a bias in the posterior density for θ. If this is true then the much stronger support for θ ∈ (0, 1/2) relative to θ = 1/2 than for θ = 0 relative to θ = 1/2 is because the first model allows θ to absorb deviations from the model due to non-random mating, rather than because loose linkage actually exists. From a frequentist viewpoint, a likelihood ratio test estimating θ would be more powerful than a test which only allows the alternative hypothesis θ = 0, even if tight linkage exists, because such a test would allow θ to absorb deviations from the model due to non-random mating. This suggests that more realistic population models might give considerably improved inferences with this sort of data. Finally, this result could be due to random variation i.e. be a 'false positive'. The results in Table 5 , and the BIC values in Table 7 , which suggest that the no-association model provides the best description of the data, encourage this view. In conclusion, prior scepticism regarding the possibility of linkage crucially affects the inference we draw from the data. There has been considerable debate about significance levels in frequentist linkage analyses, but for family-based association studies of the type discussed here anything from 0.05 to 5×10 −8 might be used, dependent on prior belief about the possibility of linkage to the locus under study (see for example Risch and Merikangas, 1996) . In our opinion the Bayesian approach, which incorporates prior information explicitly and transparently provides a more natural framework for these analyses. This paper is, as far as we are aware, the first attempt to develop methods for family-based association studies using multi-allelic markers within the Bayesian framework. As noted above, we see the Bayesian approach as having the key advantages of directly answering the question of interest and of readily allowing for the inclusion of prior information, and therefore being well suited to use as a decision making tool. In addition, the Bayesian approach facilitates the modelling of missing data, important here since often one or both parents may be unavailable for genotyping. Finally, we note that the methods developed here could be extended to cope with more complicated family structures, for example multiple affected children within the same family or missing parental information, and to analyses conditional on parental genotype analogous to the TDT of Spielman and Ewens (1996) . We hope to discuss these extensions elsewhere.
